[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Griffith et al., 1978 - Google Patents

Fractionation of heparin by affinity chromatography on covalently-bound human α-thrombin

Griffith et al., 1978

Document ID
17852497603224329791
Author
Griffith M
Kingdon H
Lundblad R
Publication year
Publication venue
Biochemical and Biophysical Research Communications

External Links

Snippet

Commerical heparin, 135 USP units/mg, was fractionated by human α-thrombin-agarose affinity chromatography. Heparin was applied to an α-thrombin-agarose column equilibrated with 0.01 M Tris HCl (pH 7.4). Unbound heparin was washed from the column with the …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Similar Documents

Publication Publication Date Title
Loscalzo et al. The interaction of platelet factor four and glycosaminoglycans
Jesty et al. Purification of Factor VII from bovine plasma: Reaction with tissue factor and activation of Factor X
Linhardt et al. Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.
Olson Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.
Holleman et al. The thrombin-like enzyme from Bothrops atrox snake venom. Properties of the enzyme purified by affinity chromatography on p-aminobenzamidine-substituted agarose.
Seegers et al. Further studies on the purification of thrombin
Björk et al. Acceleration of the Reaction between, Thrombin and Antithrombin III by Non‐stoichiometric Amounts of Heparin
Silvestri et al. The C1q inhibitor in serum is a chondroitin 4-sulfate proteoglycan.
EP0230945B1 (en) Thrombin-binding substance and process for preparing the same
Carlström et al. Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin
US4381346A (en) Isolation of plasminogen activators useful as therapeutic and diagnostic agents
Goosen et al. Inactivation of thrombin by antithrombin III on a heparinized biomaterial
Danishefsky et al. Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor
Walker Characterization of a synthetic peptide that inhibits the interaction between protein S and C4b-binding protein
US4137127A (en) Process for the preparation of thrombin-like enzymes from snake venoms
Griffith et al. Fractionation of heparin by affinity chromatography on covalently-bound human α-thrombin
Ganguly Isolation and some properties of fibrinogen from human blood platelets
Salem et al. The light chain of factor Va contains the activity of factor Va that accelerates protein C activation by thrombin.
Tollefsen et al. Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.
Sakamoto et al. Studies on the interaction between heparin and mouse bone collagenase
DANG DAI et al. Purification and properties of l‐6‐hydroxynicotine oxidase
Smith et al. A further examination of the active form of Crotalus adamanteus phospholipase A2
Miller-Andersson et al. Preparation and stability of a highly purified human thrombin standard
Modi et al. The isolation of prothrombin, factor IX and factor X from human factor IX concentrates
Vician et al. Purification of human blood clotting factor X by blue dextran agarose affinity chromatography